U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07700329) titled 'A Study to Evaluate the Blood Levels, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants' on July 09.
Brief Summary: The purpose of the study is to evaluate the drug levels, safety and tolerability of BMS-986368 in healthy Chinese participants
Study Start Date: Jan. 05, 2027
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: BMS-986368
Specified dose on specified days
OTHER: BMS-986368-matching Placebo
Specified dose of specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Celgene
Published by HT Digital Content Services with permission from Health Daily Digest....